D. Vicente Baz - Med Oncol, Hopsital Univ Virgen Macarena

L.D. Garma, D. Jimenez,D. Vicente Baz, R. Vera, B. Bermejo, S. Gonzalez,S. Pernas Simon,J.M. Sanchez Torres, B. Nasarra-Lopez, B. Fullana Grimalt, M. Rodriguez,S. de la Cruz, L. Paz, M. Sauras, M.A. Villalba, A. Artes-Rodriguez,R. Colomer Bosch,M. Quintela-Fandino

Annals of Oncology (2024): S301-S301

Cited0Views0Bibtex

60P Sacituzumab Govitecan (SG) + Pembrolizumab (pembro) in First-Line (1L) Metastatic Non-Small Cell Lung Cancer (mnsclc): Efficacy Results by Histology from the EVOKE-02 Study

F. Cappuzzo, J. Patel,B.C. Cho,M. Cobo Dols, R.M. Reyes Cabanillas,D. Vicente Baz,J. Fuentes Pradera, J. Neal,E.B. Garon,S. Mekan,F. Safavi,N. Fernando,M. Chisamore,M. Reck

ESMO Open (2024): 102639

Cited0Views0Bibtex

118MO Trastuzumab Deruxtecan (T-Dxd) and Pembrolizumab in Immuno-Oncology (Io)-Naive HER2-expressing or HER2-mutant Non-Small Cell Lung Cancer (NSCLC): Interim Analysis of a Phase Ib Study

A. Italiano, B. Besse, H. Borghaei, S. Popat, G. Anguera Palacios, A. Goncalves, M. Meurer, J. Mazieres, C. Chouaid, J. Soberino García, L. Garcia Estevez,A. Calles Blanco,D. Vicente Baz,M.J. Chisamore,D. Barrios, K. Abe, D. Haribhai, M. Rosen, B. Cunningham, L. Paz-Ares

Immuno-Oncology and Technology (2024): 100747

Cited0Views0Bibtex

OA05.04 Sacituzumab Govitecan + Pembrolizumab in 1L Metastatic Non-Small Cell Lung Cancer: Preliminary Results of the EVOKE-02 Study

B.C. Cho,M.C. Dols, R. Reyes Cabanillas,D. Vicente Baz,J. Fuentes Pradera, S. Grisanti,A.E. Gabayan, K.H. Lee,E.K. Cho,S. Mekan,F. Safavi,N. Fernando,M.J. Chisamore,M. Reck

Journal of Thoracic Oncologyno. 11 (2023): S54

Cited1Views0Bibtex

PP01.09 Genotypic Characteristics and Resistance Mutations in Advanced ALK+ NSCLC: the ALK-PATHFINDER Study

R. Lopez Castro,A. Insa Molla,E. Esteban Gonzalez,A. Gomez Rueda,D. Isla Casado,I. Barneto Aranda, C. Bayona Anton,M. Majem Tarruella,S. Peralta Munoz,R. Garcia Campelo,J. Bosch Barrera,O. J. Juan Vidal,R. Bernabe Caro,D. Vicente Baz,R. Gordo Flores,N. Carrizo Mijarra, I. Ferrer Sanchez, M. E. Lopez Munoz,S. Ponce Aix

JOURNAL OF THORACIC ONCOLOGY（2023）

Cited0Views0Bibtex

LBA11 IPSOS: Results from a Phase III Study of First-Line (1L) Atezolizumab (atezo) Vs Single-Agent Chemotherapy (chemo) in Patients (pts) with NSCLC Not Eligible for a Platinum-Containing Regimen

S. M. Lee, C. Schulz,K. Prabhash, B. Han,A. Szczesna,D. L. Cortinovis,A. Rittmeyer,D. Vicente Baz,R. Califano, L. Tuan Anh, G. Liu,F. Cappuzzo, J. G. Reyes Contreras,M. Reck, Y. Hu,S. Morris, E. K. Hoeglander, M. Connors,H. K. M. Vollan,S. Peters

ANNALS OF ONCOLOGYno. 7 (2022): S1418-S1419

Cited13Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn